Strive Health, founded in 2018, raised a $300 million equity Series D plus $250 million debt financing in 2025- a $550 million capital raise that valued the company at $1.8 billion. The company serves over 145,000 kidney-disease patients across all 50 states, partners with 6,500+ providers, and manages nearly $5 billion in annual medical spend. With support from investors like NEA, CVS Health Ventures, and CapitalG, Strive Health’s data-driven, value-based care model is positioned for rapid expansion and improved patient outcomes nationwide.